Company intelligence / Profile preview
Regenerative Processing Plant
Palm Harbor, Florida, United States
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Regenerative Processing Plant commercializes sterile human birth tissue-derived products (notably, the Regener-Eyes ophthalmic solutions) for wound healing and ocular surface treatment. The company uses proprietary cryogenic and cleaning processes for biologics manufacturing, with recent FDA warning letters regarding CGMP violations in ophthalmic drug production[5].
- Therapeutic areas
- OphthalmologyDermatology
- Modalities
- BiologicCell therapyAllograft
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Regenerative Processing Plant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenerative Processing Plant.